Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.
Soriano V, Miró JM, García-Samaniego J, Torre-Cisneros J, Núñez M, del Romero J, Martín-Carbonero L, Castilla J, Iribarren JA, Quereda C, Santín M, González J, Arribas JR, Santos I, Hernández-Quero J, Ortega E, Asensi V, del Pozo MA, Berenguer J, Tural C, Clotet B, Leal M, Mallolas J, Sánchez-Tapias JM, Moreno S, Gatell JM, Téllez MJ, Rubio R, Ledesma E, Domingo P, Barreiro P, Pedreira J, Romero M, González-Lahoz J, Lissen E. Soriano V, et al. Among authors: mallolas j. J Viral Hepat. 2004 Jan;11(1):2-17. doi: 10.1046/j.1365-2893.2003.00491.x. J Viral Hepat. 2004. PMID: 14738553 Review.
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
Berenguer J, González-García J, López-Aldeguer J, Von-Wichmann MA, Quereda C, Hernando A, Sanz J, Tural C, Ortega E, Mallolas J, Santos I, Miralles P, Montes ML, Bellón JM, Esteban H; GESIDA HIV/HCV cohort. Berenguer J, et al. Among authors: mallolas j. J Antimicrob Chemother. 2009 Jun;63(6):1256-63. doi: 10.1093/jac/dkp106. Epub 2009 Apr 10. J Antimicrob Chemother. 2009. PMID: 19363085 Clinical Trial.
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.
Vidal C, García F, Gatell JM, Leal M, Clotet B, Pumarola T, Miró JM, Mallolas J, Ruiz L, Cruceta A, Tortajada C. Vidal C, et al. Among authors: mallolas j. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):55-60. doi: 10.1097/00042560-199809010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9732070 Clinical Trial.
Once-daily antiretroviral therapy: Spanish Consensus Statement.
Pulido F, Ribera E, Moreno S, Muñoz A, Podzamczer D, del Pozo MA, Rivero A, Rodríguez F, Sanjoaquín I, Teira R, Viciana P, Villalonga C, Antela A, Carmena J, Ena J, Gonzalez E, Kindelán JM, Mallolas J, Márquez M, Martínez E. Pulido F, et al. Among authors: mallolas j. J Antimicrob Chemother. 2005 Nov;56(5):808-18. doi: 10.1093/jac/dki320. Epub 2005 Sep 8. J Antimicrob Chemother. 2005. PMID: 16150862
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals.
Gatell JM, Leal M, Mallolas J, Vidal C, Pumarola T, Parra R, Padró S, Caruz A, Falgueras T, Rey C, Sánchez-Quijano A, Torres Y, Lissen E, Jiménez de Anta MT, Soriano E. Gatell JM, et al. Among authors: mallolas j. Antivir Ther. 1996 Apr;1(2):105-12. Antivir Ther. 1996. PMID: 11321180 Clinical Trial.
Lymphoid tissue viral burden and duration of viral suppression in plasma.
Martínez E, Arnedo M, Giner V, Gil C, Caballero M, Alós L, García F, Holtzer C, Mallolas J, Miró JM, Pumarola T, Gatell JM. Martínez E, et al. Among authors: mallolas j. AIDS. 2001 Aug 17;15(12):1477-82. doi: 10.1097/00002030-200108170-00004. AIDS. 2001. PMID: 11504979
383 results